Across TCGA pan-cancer cohorts, SLURP1 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated SLURP1 data layer compared with 21 for mass-spec protein and 2 for mass-spec protein.
The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher SLURP1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated SLURP1 expression acts as an unfavorable survival marker.
SKCM are the cancer types where SLURP1 Mutation most reproducibly stratifies survival.